Medtronic (MDT) Receives FDA Approval of Expanded MRI Labeling for Medtronic Percept PC and Percept RC, as Well as Medtronic Activa PC, RC and SC
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $92.77 --0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.1%
Revenue Growth %: +5.3%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.1%
Revenue Growth %: +5.3%
Join SI Premium – FREE
Medtronic (NYSE: MDT) Receives FDA Approval of Expanded MRI Labeling for Medtronic Percept PC and Percept RC, as Well as Medtronic Activa PC, RC and SC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Upgrades Targa Resources (TRGP) to Buy, 'Wet Gas Fuels Growth'
- KeyBanc Reiterates Overweight Rating on Planet Fitness (PLNT)
- Lennar (LEN) Reiterated at Market Perform by Citizens as Incentive Rate Improves
Create E-mail Alert Related Categories
Corporate News, FDARelated Entities
Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
